Scotiabank Issues Pessimistic Estimate for Cameco Earnings

Cameco Corporation (NYSE:CCJ) (TSE:CCO) – Analysts at Scotiabank lowered their FY2027 earnings per share (EPS) estimates for shares of Cameco in a research report issued to clients and investors on Friday, April 17th. Scotiabank analyst O. Wowkodaw now expects that the basic materials company will post earnings per share of $1.47 for the year, down from their previous forecast of $1.48. The consensus estimate for Cameco’s current full-year earnings is $1.57 per share.

Several other equities research analysts also recently commented on CCJ. Canadian Imperial Bank of Commerce lifted their target price on shares of Cameco to $202.00 in a research report on Monday, March 9th. Zacks Research downgraded shares of Cameco from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 18th. The Goldman Sachs Group reiterated a “buy” rating and set a $131.00 target price on shares of Cameco in a research report on Wednesday, February 4th. Raymond James Financial reiterated an “outperform” rating on shares of Cameco in a research report on Wednesday, January 14th. Finally, Royal Bank Of Canada lifted their target price on shares of Cameco from $150.00 to $160.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 17th. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $150.40.

Cameco Stock Down 5.7%

NYSE:CCJ opened at $116.54 on Tuesday. The firm’s 50 day simple moving average is $114.17 and its 200 day simple moving average is $103.74. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.47 and a quick ratio of 1.68. Cameco has a one year low of $39.89 and a one year high of $135.24. The company has a market cap of $50.76 billion, a PE ratio of 120.15 and a beta of 1.02.

Cameco (NYSE:CCJ) (TSE:CCO) last released its quarterly earnings data on Friday, February 13th. The basic materials company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.07. Cameco had a return on equity of 9.35% and a net margin of 17.00%.The company had revenue of $874.57 million for the quarter, compared to the consensus estimate of $782.13 million. During the same quarter last year, the business posted $0.36 EPS. Cameco’s revenue for the quarter was up 1.5% on a year-over-year basis.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Contravisory Investment Management Inc. acquired a new position in shares of Cameco in the 1st quarter worth approximately $335,000. Kestra Private Wealth Services LLC lifted its position in shares of Cameco by 7.1% in the 1st quarter. Kestra Private Wealth Services LLC now owns 6,864 shares of the basic materials company’s stock worth $746,000 after purchasing an additional 458 shares during the period. Ritholtz Wealth Management lifted its position in shares of Cameco by 73.5% in the 1st quarter. Ritholtz Wealth Management now owns 11,491 shares of the basic materials company’s stock worth $1,248,000 after purchasing an additional 4,869 shares during the period. RFG Advisory LLC acquired a new position in shares of Cameco in the 1st quarter worth approximately $671,000. Finally, Brown Lisle Cummings Inc. lifted its position in shares of Cameco by 3,200.0% in the 1st quarter. Brown Lisle Cummings Inc. now owns 297 shares of the basic materials company’s stock worth $32,000 after purchasing an additional 288 shares during the period. Institutional investors and hedge funds own 70.21% of the company’s stock.

Cameco News Roundup

Here are the key news stories impacting Cameco this week:

• Positive Sentiment: William Blair initiated coverage with an Outperform rating and a $165 fair‑value estimate, a material bullish endorsement that supports longer‑term upside for CCJ. William Blair Initiates Coverage
• Positive Sentiment: Analyst and investor commentary (Seeking Alpha) recommends buying Cameco on dips under ~$120, reinforcing support from income/stability narratives in the nuclear/uranium theme. Buy on Dip Thesis
• Neutral Sentiment: Comparative coverage with peers (Energy Fuels / UUUU) highlights a tradeoff: Cameco offers scale and stability while some rivals offer faster growth and REE exposure — useful context for investors rebalancing within the uranium complex. CCJ vs UUUU Comparison
• Negative Sentiment: Scotiabank trimmed its FY2027 EPS estimate for Cameco marginally (from $1.48 to $1.47), and consensus full‑year estimates remain above that level — a modest negative signal for near‑term earnings expectations. MarketBeat Coverage
• Negative Sentiment: Market‑coverage pieces reported that CCJ posted a larger intraday decline than the broader market, reflecting short‑term profit taking or rotation away from cyclicals despite the bullish initiation. Zacks: Larger Drop Report

Cameco Company Profile

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.